Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

3.437 -0.103 (-2.91%)

Delayed Quote Updated: 9:52 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Revelation Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session. ↗

January 28, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

These stocks are moving in today's session ↗

January 28, 2025

Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

The market is filled with gapping stocks in Tuesday's session. ↗

January 28, 2025

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025

January 24, 2025

From Revelation Biosciences Inc.

Via Business Wire

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

January 21, 2025

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025

January 13, 2025

From Revelation Biosciences, Inc.

Via Business Wire

Nasdaq Grants Revelation Biosciences Inc. Continued Listing

January 06, 2025

From Revelation Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 03, 2024

Via Benzinga

Why Revelation Biosciences (REVB) Stock Is Down 38% ↗

December 03, 2024

Revelation Biosciences shares are trading lower by 38% during Tuesday's session. The company agreed to a $4M warrant exercise, closing December 3.

Via Benzinga

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

December 03, 2024

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

December 02, 2024

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

November 12, 2024

From Revelation Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 11, 2024

Via Benzinga

Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket ↗

November 11, 2024

Via Benzinga

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024

November 08, 2024

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10

September 24, 2024

From Revelation Biosciences, Inc.

Via Business Wire

Nasdaq Down Over 200 Points; Williams-Sonoma Shares Tumble After Q2 Results ↗

August 22, 2024

Via Benzinga

Gold Down Over 1%; US Initial Jobless Claims Increase ↗

August 22, 2024

Via Benzinga

Dow Jumps 100 Points; BJ's Wholesale Earnings Top Estimates ↗

August 22, 2024

Via Benzinga

Topics Stocks

Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

August 22, 2024

Via Benzinga

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

August 21, 2024

From Revelation Biosciences Inc.

Via Business Wire

US Stocks Higher; Target Posts Upbeat Earnings ↗

August 21, 2024

Via Benzinga

Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

August 21, 2024

Via Benzinga

Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

August 14, 2024

Via Benzinga

REVB Stock Earnings: Revelation Biosciences Misses EPS for Q2 2024 ↗

August 09, 2024

REVB stock results show that Revelation Biosciences missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024

August 09, 2024

From Revelation Biosciences, Inc.

Via Business Wire

Why Is Nano-Cap Revelation Biosciences Stock Skyrocketing On Monday? ↗

June 24, 2024

Revelation Biosciences reveals positive safety and biomarker data from its Phase 1 study (RVL-HV02) of Gemini. The study met its primary endpoint and identified a maximum tolerated dose.

Via Benzinga

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

June 24, 2024

From Revelation Biosciences, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.